Titan Pharmaceuticals, Inc.
(NASDAQ : TTNP)

( )
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield

Message Boards

...

News

...
Health Technology » Biotechnology

Company Profile

Pro-Titan Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in developing proprietary therapeutics primarily for the treatment of serious medical disorders. It uses proprietary long-term drug delivery platform ProNeura and focuses primarily on innovative treatments for select chronic diseases. The company was founded by Louis R. Bucalo in February 7, 1992 and is headquartered in South San Francisco, CA.